Michael J. Embler net worth and biography

Michael Embler Biography and Net Worth

Director of Ventas

Mr. Embler brings to our Board deep investment, finance and healthcare expertise. He is widely recognized for his success and insights as an institutional investor and seasoned board member, with deep experience across a broad range of industries, including healthcare, capital intensive industries and finance. As the Chief Investment Officer of Franklin Mutual Advisers, he oversaw over $85 billion in assets under management and 25 investment professionals. He is also an experienced director, with over 25 years of public board experience, including in the healthcare space.

What is Michael J. Embler's net worth?: The estimated net worth of Michael J. Embler is at least $1.53 million as of June 3rd, 2026. Embler owns 19,202 shares of Ventas stock worth more than $1,525,618 as of June 8th. This net worth estimate does not reflect any other investments that Embler may own. Learn More about Michael J. Embler's net worth.
How do I contact Michael J. Embler?: The corporate mailing address for Embler and other Ventas executives is 353 N. CLARK STREET SUITE 3300, CHICAGO IL, 60654. Ventas can also be reached via phone at (877) 483-6827 and via email at [email protected]. Learn More on Michael J. Embler's contact information.
Has Michael J. Embler been buying or selling shares of Ventas?: In the last ninety days, Michael J. Embler has bought $197,025.00 in shares of Ventas stock. Most recently, on Wednesday, June 3rd, Michael J. Embler bought 2,500 shares of Ventas stock. The stock was acquired at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the transaction, the director now directly owns 19,202 shares of the company's stock, valued at $1,513,309.62. Learn More on Michael J. Embler's trading history.
Who are Ventas' active insiders?: Ventas' insider roster includes Peter Bulgarelli (EVP, President & CEO), Debra Cafaro (Chairman & CEO), Michael Embler (Director), Richard Gilchrist (Director), Gregory Liebbe (CAO), Robert Probst (CFO), Walter Rakowich (Director), and Carey Roberts (Executive Vice President, General Counsel and Ethics & Compliance Officer). Learn More on Ventas' active insiders.
Are insiders buying or selling shares of Ventas?: In the last year, Ventas insiders bought shares 1 times. They purchased a total of 2,500 shares worth more than $197,025.00. In the last year, insiders at the real estate investment trust sold shares 34 times. They sold a total of 1,052,636 shares worth more than $76,069,055.84. The most recent insider tranaction occured on June, 3rd when Director Michael J Embler bought 2,500 shares worth more than $197,025.00. Insiders at Ventas own 0.5% of the company. Learn More about insider trades at Ventas.
Information on this page was last updated on 6/3/2026.

Michael J. Embler Insider Trading History at Ventas

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/3/2026	Buy	2,500	$78.81	$197,025.00	19,202

Michael J. Embler Buying and Selling Activity at Ventas

Ventas Company Overview

Ventas Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. The Company's growth is fueled by its senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas leverages its unmatched operational expertise, data-driven insights from its Ventas Operational InsightsTM platform, extensive relationships and strong financial position to achieve its goal of delivering outsized performance across approximately 1,400 properties. The Ventas portfolio is composed of senior housing communities, outpatient medical buildings, research centers and healthcare facilities in North America and the United Kingdom. The Company benefits from a seasoned team of talented professionals who share a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

Today's Range

Now: $79.24

$79.02

$82.10

50 Day Range

MA: $85.05

$78.92

$90.35

2 Week Range

Now: $79.24

$61.76

$91.06

Volume

1,155,770 shs

Average Volume

3,576,774 shs

Market Capitalization

$38.52 billion

P/E Ratio

144.20

Dividend Yield

2.54%

Beta

0.71